Navigation Links
Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products
Date:5/17/2013

New York, New York (PRWEB) May 17, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that Johnson & Johnson (J&J)’s DePuy Orthopaedics Inc. has said in a May 16, 2013, statement that it will stop selling some of its metal-on-metal and ceramic-on-metal hip replacement products; specifically, the metal liners in the Ultamet Metal-on-Metal Articulation and the Complete Ceramic-on-Metal Acetabular Hip System will no longer be available worldwide after Aug. 31, according to a May 17, 2013, Bloomberg report, which added that the DePuy unit will stop selling related products in 2014.

The effort is meant to pare down the company’s metal hip implant product offering, it said in the release. The Pinnacle Cup all-metal hip implant will continue to be available, however.

The U.S. Food and Drug Administration (FDA)’s proposed regulatory change is another factor in the decision to discontinue Ultamet, in particular, the company added in its statement. The FDA announced in January plans to require all metal-on-metal hip implants cleared for release through the 510(k) process to now be approved through the Premarket Approval (PMA) process. Ultamet was cleared for sale through the 510(k) process in 2000, the company said. As the May 17, 2013, Bloomberg report noted, the 510(k) process is less extensive and allows manufacturers to compare their new offerings with similar products already on the market. The FDA now wants all-metal hip implants to undergo more rigorous study of the PMA process.

The reason for this is that questions of the safety of metal implants have been on the rise in recent years. Safety concerns helped reduce the metal-on-metal hip implants from roughly 20% of the market in 2007 to less than 2% last year, with total industry sales plunging 90% over the same period, according to the statement from J&J. The FDA issued a report on Jan. 18, 2013, in which it highlighted several possible adverse health reactions some patients could have to metal implanted in their body:

  •     Loss or reduction of joint function.
  •     Adverse tissue reaction.
  •     Increased risk of premature device failure.
  •     Infection.

“Metal implants have the potential to be quite dangerous and the FDA has picked up on this, which is why it is requiring more stringent testing for metal implants than the earlier 510(k) process,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP. “We know that recipients of the Pinnacle metal-on-metal implant, many of whom are our clients, have suffered from a range of complications, including the need for a revision surgery.”

Parker Waichman LLP filed dozens of lawsuits alleging that the DePuy Pinnacle hip implant is defective. The firm’s most recent filing was on March 19, 2013 in the U.S. District Court for the Northern District of Texas, where it is one of many cases pending in the multidistrict litigation (MDL) entitled In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation (MDL No. 3:11-md-02244).

Parker Waichman LLP continues to offer free legal consultations to victims of DePuy Pinnacle and other metal-on-metal hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with an all-metal DePuy Pinnacle Hip Implant or other metal-on-metal hip replacement device, please contact their office by visiting the firm's DePuy Pinnacle hip implant lawsuits page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/depuy_metal_implants/05/prweb10747045.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mississippi Woman’s Injuries Allegedly Caused by Ethicon Inc.’s Transvaginal Mesh Device; Parker Waichman LLP Files Lawsuit
2. Da Vinci Surgical Robot Injury Website Launched by Parker Waichman LLP to Help Update the Public on Latest Developments
3. Diabetes Drug Actos Caused Bladder Cancer and Wrongful Death of Ohio Man, Alleges Lawsuit Filed by Parker Waichman LLP
4. Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to a Training Specialist Who Said She Taught Doctors How to Use the Robot—Not Operate on Patients
5. Parker Waichman LLP Responds to an Intuitive Surgical Notice that the da Vinci Surgical Robot, Due to a Defect, Can Electrically Burn a Patient During Surgery
6. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
7. New York Woman Suffers Injuries Allegedly Due to Boston Scientific’s Transvaginal Mesh Device, Lawsuit Filed by Parker Waichman LLP
8. In Light of New Research Findings, Parker Waichman LLP Warns about Risk of Texting While Driving
9. Texas Woman Alleges Actos Caused her Bladder Cancer, Parker Waichman LLP Files Lawsuit on Victim’s Behalf
10. Parker Waichman LLP Files Class Action Lawsuit on Behalf of Consumers Who’ve Purchased Azek Decking
11. Wisconsin Woman Alleges She was Injured by Transvaginal Mesh Devices in Lawsuit Filed by Parker Waichman LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
(Date:5/5/2016)... ... May 05, 2016 , ... The ... electronic cigarettes, requiring e-cigarette manufacturers to submit their products through an arduous federal ... all vaping products that entered the market since February 15, 2007. That would ...
(Date:5/5/2016)... FL (PRWEB) , ... May 05, 2016 , ... ... in Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative to ... Implant. Since first offering the procedure in April of 2015, Florida Hospital Pepin ...
(Date:5/5/2016)... ... May 05, 2016 , ... This weekend, from Friday, May 6 - Sunday, May 8, ... terrain at the first Team Semper Fi Mountain Bike Camp, hosted in conjunction with ... bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with the injured veterans ...
(Date:5/5/2016)... ... 2016 , ... Phycologia – While it is ... researchers Juntian Xu and Kunshan Gao tested the magnitude of this phenomenon on ... photosynthetically active radiation (i.e. the white light in our visible spectrum) was not ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Research and ... Acute lymphocytic Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic ...
(Date:5/3/2016)... DUBLIN , May 4, 2016 ... the "Global Cancer Stem Cell Therapy Market Outlook ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has ... therapeutics are expected to be developed in coming years. ... these techniques. Cancer stem cell therapies are also expected ...
(Date:5/3/2016)... , May 3, 2016 ACME ... Whelan and Delaware County Councilman ... Nasal Spray in all ACME pharmacies across ... for Disease Control and Prevention (CDC), naloxone has saved 26,463 lives ... officers in Delaware County were authorized to ...
Breaking Medicine Technology: